CLINICAL IMMUNOLOGY
Urine interleukin-6, interleukin-8 and transforming growth factor β1 in infants with urinary tract infection and asymptomatic bacteriuria
Submission date: 2016-06-12
Final revision date: 2016-06-28
Acceptance date: 2016-07-26
Publication date: 2016-10-25
Cent Eur J Immunol 2016;41(3):260-267
KEYWORDS
urinary tract infectionasymptomatic bacteriuriainterleukin-6interleukin-8transforming growth factor β1
ABSTRACT
Introduction: Urinary tract infection (UTI) occurs in 1.1% of girls and 1.4% of boys during the first year of life. Asymptomatic bacteriuria (ABU) is usually detected incidentally in 0.9% of girls and 2.5% of boys at this age. The aim of the study was to assess the usefulness of measurement of pro-inflammatory urine interleukin (IL)-6 and IL-8 concentrations and anti-inflammatory transforming growth factor 1 (TGF-1) level in infants with febrile UTI, non-febrile UTI and ABU.
Material and methods: A total of 35 children, mean age 6.14 ±3.47 months, were divided into three groups: group I – febrile UTI (n = 13), group II – non-febrile UTI (n = 13) and group III – ABU (n = 9). At the time of enrollment urine IL-6, IL-8, TGF-β1 and serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WBC) were measured. Renal ultrasound was performed in all children, 99mTc-dimercaptosuccinic acid scintigraphy (DMSA) and voiding cystourethrography in children with UTI.
Results: Urine concentrations of IL-6 and IL-8 were significantly higher in febrile UTI compared to those with non-febrile UTI and ABU (p < 0.5, p < 0.01) and positively correlated with CRP, ESR and WBC (p < 0.01). Urine levels of TGF-β1 were significantly higher in children with febrile UTI compared to those with ABU (p < 0.05) and positively correlated with WBC (p < 0.01). Inflammatory changes in the DMSA scan were detected in 66.6% of children with UTI. No significant difference in frequency of an abnormal DMSA scan compared to a normal scan was found in groups with febrile and non-febrile UTI. No relations between urine cytokines, systemic inflammatory markers and changes in DMSA scan were observed. The cutoff value for detection of inflammatory changes in the DMSA scan for IL-8 was 120 pg/mg creatinine (Cr) and 40 pg/mg Cr for TGF-β1. Based on this value, the sensitivity for IL-8 was 58.3%, specificity 100% and for TGF-β1 66.7% and 83.7%, respectively.
Conclusions: We found significant differences in children with febrile UTI and ABU regarding urine IL-6, IL-8 and TGF-β1 levels. Urine cytokines and systemic inflammatory markers do not differentiate between upper and lower UTI in infants.
Material and methods: A total of 35 children, mean age 6.14 ±3.47 months, were divided into three groups: group I – febrile UTI (n = 13), group II – non-febrile UTI (n = 13) and group III – ABU (n = 9). At the time of enrollment urine IL-6, IL-8, TGF-β1 and serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WBC) were measured. Renal ultrasound was performed in all children, 99mTc-dimercaptosuccinic acid scintigraphy (DMSA) and voiding cystourethrography in children with UTI.
Results: Urine concentrations of IL-6 and IL-8 were significantly higher in febrile UTI compared to those with non-febrile UTI and ABU (p < 0.5, p < 0.01) and positively correlated with CRP, ESR and WBC (p < 0.01). Urine levels of TGF-β1 were significantly higher in children with febrile UTI compared to those with ABU (p < 0.05) and positively correlated with WBC (p < 0.01). Inflammatory changes in the DMSA scan were detected in 66.6% of children with UTI. No significant difference in frequency of an abnormal DMSA scan compared to a normal scan was found in groups with febrile and non-febrile UTI. No relations between urine cytokines, systemic inflammatory markers and changes in DMSA scan were observed. The cutoff value for detection of inflammatory changes in the DMSA scan for IL-8 was 120 pg/mg creatinine (Cr) and 40 pg/mg Cr for TGF-β1. Based on this value, the sensitivity for IL-8 was 58.3%, specificity 100% and for TGF-β1 66.7% and 83.7%, respectively.
Conclusions: We found significant differences in children with febrile UTI and ABU regarding urine IL-6, IL-8 and TGF-β1 levels. Urine cytokines and systemic inflammatory markers do not differentiate between upper and lower UTI in infants.
REFERENCES (41)
1.
Hansson S, Bollgren I, Esbjörner E, et al. (1999): Urinary tract infections in children below two years of age: a quality assurance project in Sweden. Acta Paediatr 88: 270-274.
2.
American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection Practice Guideline (1999): The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 103: 843-852.
3.
Wettergren B, Jodal U (1990): Spontaneous clearance of asymptomatic bacteriuria in infants. Acta Pediatr Scand 79: 300-304.
4.
Tullus K (2011): Difficulties in diagnosing urinary tract infections in small children. Pediatr Nephrol 26: 1923-1926.
5.
Raz R (2003): Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents 22 (Suppl. 2): S45-S47.
6.
Ragnarsdóttir B, Svanborg C (2012): Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 27: 2017-2029.
7.
Gürgöze MK, Akarsu S, Yilmaz E, et al. (2005): Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 20: 1445-1448.
8.
Gokce I, Alpay H, Biyikli N, et al. (2010): Urinary levels of interleukin-6 and interleukin-8 in patients with vesicoureteral reflux and renal parenchymal scar. Pediatr Nephrol 25: 905-912.
9.
Sheu JN, Chen MC, Lue KH, et al. (2006) Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine 36: 276-282.
10.
Zarkesh M, Sedaghat F, Heidarzadeh A, et al. (2014): Diagnostic value of IL-6, CRP, WBC and absolute neutrophil count to predict serious bacterial infection in febrile infants. Acta Med Iran 53: 408-411.
11.
Galanakis E, Bitsori M, Dimitriou H, et al. (2006): Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Pediatrics 117: e863-e867.
12.
Chen X, Zhu W, Al-Hayek S, et al. (2015): Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction. Int Urol Nephrol 47: 33-37.
13.
Cotton SA, Gbadegesin RA, Williams S, et al. (2002): Role of TGF-1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int 61: 61-67.
14.
Farmaki E, Papachristou F, Winn RM, et al. (2005): Transforming growth factor-1 in the urine of young children with urinary tract infection. Pediatr Nephrol 20: 180-183.
15.
Mandelia A, Bajpai M, Agarwala S, et al. (2013): The role of urinary TGF-1, TNF-, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 28: 1991-2001.
16.
Zieg J, Blahova K, Seeman T, et al. (2011): Urinary transforming growth factor-1 in children with obstructive uropathy. Nephrology 16: 595-598.
17.
Grenda R, Wühl, Litwin M, et al. (2007): Urinary excretion of endothelin-1 (ET-1), transforming growth factot-beta1 (TGF-beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial. Nephrol Dial Transplant 22: 3487-3494.
18.
Doganis D, Siafas K, Mavrikou M, et al. (2008): Does early treatment of urinary tract infection prevent renal damage? Pediatrics 120: e922-e928.
19.
Jobs K, Straż-Żebrowska E, Placzyńska M, et al. (2014): Interleukin-18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis. Cent Eur J Immunol 39: 384-391.
20.
Lee HE, Kim DK, Kang HK, et al. (2015): The diagnosis of febrile urinary tract infection in children may be facilitated by urinary biomarkers. Pediatr Nephrol 30: 123-130.
21.
Mahyar A, Ayazi P, Maleki MR, et al. (2013): Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children. Korean J Pediatr 56: 218-223.
22.
Galanakis E, Bitsori M, Dimitriou H, et al. (2007): Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis. Int Urol Nephrol 39: 581-585.
23.
Benson M, Jodal U, Agace W, et al. (1996): Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis 174: 1080-1084.
24.
Kjölvmark C, Tschernij E, Öberg J, et al. (2016): Distinguishing asymptomatic bacteriuria from urinary tract infection in the elderly – the use of urine levels of heparin-binding protein and interleukin-6. Diagn Microbiol Infect Dis 85: 243-248.
25.
Mishra OP, Abhinay A, Prasad R (2013): Urinary infection in children. Indian J Pediatr 80: 838-843.
26.
Yun KW, Kim HY, Park HK, et al. (2014): Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J Microbiol Immunol Inf 47: 455-461.
27.
Pecile P, Miorin E, Romanello C, et al. (2009): Age-related parenchymal lesions in children with first febrile urinar tract infections. Pediatrics 124: 23-29.
28.
Spasojević-Dimitrijeva B, Živkowić M, Stankowić A, et al. (2010): The IL-6-174G/C polymorphism and renal scarring in children with first acute pyelonephritis. Pediatr Nephrol 25: 2099-2106.
29.
Shaikh N, Borrell JL, Evron J, Leeflang MM (2015): Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for diagnosis of acute pyelonephritis in children. Cochrane Database Syst Rev 1: CD009185.
30.
Roilidies E, Papachristou F, Gioulekas E, et al. (1999): Increased urine interleukine-6 concentrations correlate with pyelonephitic changes on 99mTc-dimercaptosuccinic acid scan in neonates with urinary tract infections. J Infect Dis 180: 904-907.
31.
Rodriguez LM, Robles B, Marugán JM, et al. (2008): Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections. Pediatr Nephrol 23: 429-433.
32.
Krzemień G, Roszkowska-Blaim M, Kostro I, et al. (2004): Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. Med Sci Monit 10: CR593-597.
33.
Sheu JN, Chen MC, Chen SM, et al. (2009): Relationship between serum and urine interleukin-6 elevations and renal scaring in children with acute pyelonephritis. Scan J Urol Nephrol 43: 133-137.
34.
Mahyar A, Ayazi P, Yarigarravesh MH, et al. (2015): Serum interleukin-8 is not a reliable marker for prediction of vesicoureteral reflux in children with febrile urinary tract infection. Int Braz J Urol 41: 1160-1166.
35.
Mohkam M, Karimi A, Karimi H, et al. (2008): Urinary interleukin-8 in acute pyelonephitis of children: a before-after study. Iran J Kidney Dis 2: 193-196.
36.
Kassir K, Vargas-Shiraishi O, Zaldivar F, et al. (2001): Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact. Clin Diagn Lab Immunol 8: 1060-1063.
37.
Jantausch BA, O’Donnell R, Wiedermann BL (2000): Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr Nephrol 15: 236-240.
38.
Renata Y, Jassar H, Katz R, et al. (2013): Urinary concentration of cytokines in children with acute pyelonephritis. Eur J Pediatr 172: 769-774.
39.
Gorczyca D, Augustyniak D, Basiewicz-Worsztynowicz B, Karnas-Kalemba W and IP-10 levels in children with urinary tract infections. Adv Clin Exp Med 23: 933-938.
40.
Tramma D, Hatzistylianou M, Gerasimou G, Lafazanis V (2012): Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring. Pediatr Nephrol 27: 1525-1530.
41.
Rodríguez LM, Robles B, Marugán JM, et al. (2013): Do serum C-reactive protein and interleukin-6 predict kidney scarring after urinary tract infection? Indian J Pediatr 80: 1002-1006.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
